Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FAAH | O00519 | 2/20 | 0.36 |
| ▸ | MGLL | Q99685 | 2/20 | 0.36 |
| ▸ | TUBB4A | P04350 | 1/20 | 0.34 |
| ▸ | TUBB | P07437 | 1/20 | 0.34 |
| ▸ | TUBA3C | P0DPH7 | 1/20 | 0.34 |
| ▸ | TUBA1B | P68363 | 1/20 | 0.34 |
| ▸ | TUBA4A | P68366 | 1/20 | 0.34 |
| ▸ | TUBB4B | P68371 | 1/20 | 0.34 |
| ▸ | TUBB3 | Q13509 | 1/20 | 0.34 |
| ▸ | TUBB2A | Q13885 | 1/20 | 0.34 |
| ▸ | TUBB8 | Q3ZCM7 | 1/20 | 0.34 |
| ▸ | TUBA3E | Q6PEY2 | 1/20 | 0.34 |
| ▸ | TUBA1A | Q71U36 | 1/20 | 0.34 |
| ▸ | TUBA1C | Q9BQE3 | 1/20 | 0.34 |
| ▸ | TUBB6 | Q9BUF5 | 1/20 | 0.34 |
| ▸ | TUBB2B | Q9BVA1 | 1/20 | 0.34 |
| ▸ | TUBB1 | Q9H4B7 | 1/20 | 0.34 |
| ▸ | BRD4 | O60885 | 1/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.33 |
| ▸ | GAA | P10253 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1516284 | 0.95 | FAAH (0.34) | FAAHMGLLTUBB4ATUBBTUBA3C | |
| SCHEMBL14200027 | 0.81 | FAAH (0.38) | FAAHMGLLTUBB4ATUBBTUBA3C | |
| SCHEMBL13178731 | 0.81 | FAAH (0.38) | FAAHMGLLTUBB4ATUBBTUBA3C | |
| SCHEMBL16574766 | 0.79 | SLC9A1 (0.53) | GAASLC9A1 | |
| SCHEMBL17083748 | 0.78 | FAAH (0.36) | FAAHMGLLTUBB4ATUBBTUBA3C | |
| SCHEMBL13963730 | 0.76 | FAAH (0.45) | FAAHMGLLTUBB4ATUBBTUBA3C | |
| SCHEMBL1667917 | 0.74 | EGLN3 (0.45) | FAAHMGLLALDH1A1GAA | |
| SCHEMBL12019911 | 0.73 | TUBB4A (0.44) | FAAHMGLLTUBB4ATUBBTUBA3C | |
| SCHEMBL12672863 | 0.73 | SLC9A1 (0.55) | FAAHMGLLTUBB4ATUBBTUBA3C | |
| SCHEMBL13173782 | 0.72 | KDM1A (0.44) | FAAHMGLLTUBB4ATUBBTUBA3C |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20180200273-A1 | Silanol Based Therapeutic Payloads | BLINKBIO INC (US) | 2018-07-19 | — | — | US | disclosed |
| US-20100240870-A1 | Composite organic-inorganic nanoclusters | SU XING | 2010-09-23 | — | — | US | disclosed |
| US-7790286-B2 | External modification of composite organic inorganic nanoclusters | INTEL CORPORATION (US) | 2010-09-07 | — | — | US | disclosed |
| US-7776547-B2 | Cellular analysis using Raman surface scanning | INTEL CORPORATION (US) | 2010-08-17 | — | — | US | disclosed |
| US-20090303461-A1 | DETECTION OF ENHANCED MULTIPLEX SIGNALS BY SURFACE ENHANCED RAMAN SPECTROSCOPY (SERS) | SUN LEI | 2009-12-10 | — | — | US | disclosed |
| US-20090069481-A1 | EXTERNAL MODIFICATION OF COMPOSITE ORGANIC INORGANIC NANOCLUSTERS | ZHANG JINGWU | 2009-03-12 | — | — | US | disclosed |
| US-7485471-B1 | Seed particles of silver, gold, and/or copper for catalyzing surface enhanced Raman scattering (SERS) substrate; specific binding members have no Raman labels attached; bound capture reagent hasRaman label, and a bound target analyte; complexing DNA, RNA, polypeptides, antibodies, antigens, polypeptides | INTEL CORPORATION (US) | 2009-02-03 | — | — | US | disclosed |
| US-20090023135-A1 | DETECTION OF ENHANCED MULTIPLEX SIGNALS BY SURFACE ENHANCED RAMAN SPECTROSCOPY | INTEL CORPORATION | 2009-01-22 | — | — | US | disclosed |
| US-20080241569-A1 | ENCAPSULATION OF RAMAN ACTIVE NANOPARTICLES | QIN HAOYU | 2008-10-02 | — | — | US | disclosed |
| US-20080152534-A1 | Self-assembling raman-active nanoclusters | INTEL CORPORATION | 2008-06-26 | — | — | US | disclosed |
| US-20080076119-A9 | Composite organic inorganic nanoclusters | SUN LEI | 2008-03-27 | — | — | US | disclosed |
| US-20070279626-A9 | Multiplexed detection of analytes in fluid solution | SUN LEI | 2007-12-06 | — | — | US | disclosed |
| US-20070048797-A1 | Composite organic inorganic nanoclusters as carriers and identifiers of tester molecules | SU XING | 2007-03-01 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090303461-A1 | DETECTION OF ENHANCED MULTIPLEX SIGNALS BY SURFACE ENHANCED RAMAN SPECTROSCOPY (SERS) | FABP1, FABP3, FABP2 | FAAH 4657/4885MGLL 3992/4885TUBB4A 3571/4885 |
| US-20180200273-A1 | Silanol Based Therapeutic Payloads | CD47, CD4, BST2 | FAAH 3066/4885MGLL 2460/4885TUBB4A 331/4885 |
| US-20100240870-A1 | Composite organic-inorganic nanoclusters | MB, NCLN, MRPS23 | FAAH 4782/4885MGLL 2079/4885TUBB4A 1738/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.